4-year survival according to baseline FibroTest, viral load ALT values and treatment.

§Survival of the severe fibrosis group was significantly lower than the two other groups (P<0.001).
§§Overall survival of the severe fibrosis group, treated or not, was significantly lower than that of paired controls (p<0.05).
*Overall survival of the 1074 HBV patients, was significantly lower than that of paired controls (p<0.05).
$P = 0.03 vs treated.
£P = 0.047 vs treated.
***Survivals of the treated patients were similar to those of the non –treated in different groups of viral load (p>0.05).
****Overall survival of the group with high viral load was lower than that of paired controls (p<0.05).
$*Overall survival of the group with elevated ALT was lower than that of paired controls (p<0.05).
We used the manufacturers' definitions of normal FT (< = 0.27), normal AT (< = 0.29) and 3 classes for viral load in IU/ml.